Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07428460
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder
* Duration of illness ≥ 6 months
* Clinically significant negative symptoms
* Must have been on a stable pharmacological treatment for at least 4 weeks before entering the study
* Clinicians will confirm that patients' negative and positive symptoms have been stable per their clinical opinion for at least 3 months.
* Participants must be able to provide informed consent
* Ability to undergo MRI scanning
Exclusion Criteria:
* Pregnancy, lactation, or an intrauterine device
* History of electroconvulsive therapy (ECT) in the past 6 months
* Use of licit or illicit substances (excluding cannabis) during the week of treatment and in the 24 hours prior to fMRI scans
* Contraindications for TMS
* Previous treatment with rTMS
* Documented history of significant intellectual disability
* Primary diagnosis of psychotic disorder secondary to a medical condition or substance-induced psychosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07428460
Study Brief:
Protocol Section:
NCT07428460